Sutro Biopharma Inc (STRO)
3.995
-0.16
(-3.73%)
USD |
NASDAQ |
May 17, 16:00
3.995
0.00 (0.00%)
After-Hours: 20:00
Sutro Biopharma Free Cash Flow: -119.18M for March 31, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| March 31, 2024 | -119.18M |
| December 31, 2023 | -115.93M |
| September 30, 2023 | -155.79M |
| June 30, 2023 | -56.85M |
| March 31, 2023 | -29.43M |
| December 31, 2022 | -4.309M |
| September 30, 2022 | -1.195M |
| June 30, 2022 | -95.71M |
| March 31, 2022 | -101.00M |
| December 31, 2021 | -97.00M |
| September 30, 2021 | -93.39M |
| Date | Value |
|---|---|
| June 30, 2021 | -84.65M |
| March 31, 2021 | -88.24M |
| December 31, 2020 | -74.93M |
| September 30, 2020 | -69.63M |
| June 30, 2020 | -65.76M |
| March 31, 2020 | -67.58M |
| December 31, 2019 | -68.50M |
| September 30, 2019 | -60.03M |
| June 30, 2019 | 3.97M |
| March 31, 2019 | 6.079M |
| December 31, 2018 | 11.13M |
Free Cash Flow Range, Past 5 Years
-155.79M
Minimum
Sep 2023
3.97M
Maximum
Jun 2019
-72.26M
Average
-72.28M
Median
Free Cash Flow Benchmarks
| AnaptysBio Inc | -134.14M |
| ABVC BioPharma Inc | -4.257M |
| Reviva Pharmaceuticals Holdings Inc | -32.10M |
| Flora Growth Corp | -8.63M |
| Journey Medical Corp | 1.177M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -64.74M |
| Cash from Investing (Quarterly) | 64.10M |
| Cash from Financing (Quarterly) | -3.429M |
| Free Cash Flow Per Share (Quarterly) | -1.061 |
| Free Cash Flow to Equity (Quarterly) | -61.13M |
| Free Cash Flow to Firm (Quarterly) | -59.89M |
| Free Cash Flow Yield | -48.85% |